STATEMENT OF WORK Blood Bank Reagents Transaction #501-18-1-107-0001 BACKGROUND: The New Mexico VA Healthcare System (NMVAHCS), Pathology and Laboratory Medicine Service (P&LMS), blood bank must have the ability to perform ABO typing using the tube method, as it provides a faster, less expensive method. This method is also used as backup method of testing for the screening and identification of antibodies. Policies, procedures, and staff training have all taken place based upon these reagents. Any reagent changes to this critical patient testing would require extensive validation, is very costly, and time consuming. SCOPE: The New Mexico VA Healthcare System (NMVAHCS), Pathology and Laboratory Medicine Service (P&LMS), blood bank section requires a contract for a base year and four option years for FDA approved reagents to detect and identify ABO/Rh, other red cell antigens, and antibodies in human blood prior to blood transfusion. The NMVAHCS requires a monthly standing order of FDA approved blood bank reagents to detect and identify ABO/Rh, other red cell antigens, and antibodies in human blood prior to blood transfusion. SPECIFIC TASKS: Delivery of the following estimated quantities must be made by means of a monthly standing order: Item # Reagent Product Code Estimated Annual Volume Unit 1 ALBAcyte Reverse Cells-A1 Z401U 39 ea 2 ALBAcyte Reverse Cells-A2 Z406U 13 ea 3 ALBAcyte Reverse Cells B Z411U2345 39 ea 4 ALBAcyte IgG Sensitized Cells Z441U-1 39 ea 5 ALBAcyte Screening Cells Z451U 26 pk 6 ALBAcyte 16 Cell Identification Panel Z473U 13 pk 7 ALBAcyte QC Kit Z481U 13 kt 8 ALBAcyte C3 Coated Red Blood Cells Z482U 13 ea 9 ALBAclone Anti-A Z001U-10 3 ea 10 ALBAclone Anti-B Z015U-10 3 ea 11 ALBAclone Anti-D blend Z041U-10 3 ea 12 ALBAcheck Anti-D Control Z271U-10 3 ea 13 ALBAhance LISS additive Z333U 3 ea - Estimated yearly shipping charge - EST CORRELATION: Vendor shall provide the facility with sufficient reagents to perform correlation studies. Throughout the life of the agreement, the vendor shall provide assistance to the user for all troubleshooting issues and additional tests as needed. SERVICE: Vendor shall provide technical support. For reagent with hazardous constituents, vendor shall provide a mechanism for the laboratory to meet local discharge requirements. The vendor shall supply information regarding any hazardous chemicals (see Other , below). OTHER: In the event that any reagent is found to be defective and unsuitable for use, or the contractor has filed to comply with the requirements of routine supply deliver, the contractor shall deliver the reagent within a period of 24 hours after the receipt of the verbal order for priority delivery from the facility. If either circumstance has occurred, the vendor shall deliver to the facility, in the most expeditious manner possible, without additional cost to the facility, the necessary reagent in sufficient quantity so testing is not delayed. This contract should assist the NMVAHCS to pursue the goal of being a good steward in our community by eliminating, minimizing or mitigating adverse environmental impacts. The following chemicals have been targeted by the EPA specifically for reductions and feasible elimination. Please list any reagents (and in what concentration) that contain the following chemicals: Benzene Carbon Tetrachloride Chloroform Dischloromethane Methyl ethyl Ketone Toluene Methyl isobutyl Ketone Xylene Tetrachloro-ethane Cadmium 1,1,1-Trichloro-ethane Chromium Trichloro-ethylene Cyanid Lead Mercury Nickel PERFORMANCE MONITORING: The COR will ensure that product has been received for all charges listed on invoices. Blood bank will notify COR if there is any delay in receipt of monthly standing order. SECURITY REQUIREMENTS: This is for reagents and supplies only. The C&A requirements do not apply. The Security Accreditation Package is not required. GOVERNMENT FURNISHED EQUIPMENT (GFE)/GOVERNMENT FURNISHED INFORMATION: No government furnished equipment nor information will be provided to the contractor. RISK CONTROL: All cellular reagents will be handled with standard precautions. PLACE OF PERFORMANCE: New Mexico VA Healthcare System 1501 San Pedro SE (P&LMS 113) Albuquerque, New Mexico 87108 PERIOD OF PERFORMANCE: Base Year: 10/1/2017 thru 9/30/2018 Option Year 1: 10/1/2018 thru 9/30/2019 Option Year 2: 10/1/2019 thru 9/30/2020 Option Year 3: 10/1/2020 thru 9/30/2021 Option Year 4: 10/1/2021 thru 9/30/2022
